Quantification of von Willebrand Factor and von Willebrand Factor Propeptide in Patients with End Stage Renal Disease

被引：0
|
作者：
Davis, Rachael [1 ]
Bansal, Vinod [1 ]
Litinas, Evangelos [1 ]
Rahman, Saudur [1 ]
Hoppensteadt, Debra [1 ]
Conway, Brooke [2 ]
Fareed, Jawed [1 ]
机构：
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[2] GTI Diagnost, Waukesha, WI USA
来源：
FASEB JOURNAL | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Von Willebrand factor propeptide compared to von Willebrand factor as plasma marker of endothelial activation in systemic sclerosis.
    Scheja, A
    Wildt, M
    Wollheim, F
    Akesson, A
    Vischer, U
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S207 - S207
  • [42] Von Willebrand factor contribution to pathophysiology outside of von Willebrand disease
    Mojiri, Anahita
    Alavi, Parnian
    Jahroudi, Nadia
    MICROCIRCULATION, 2019, 26 (04)
  • [43] Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance
    Ozel, A. B.
    McGee, B.
    Siemieniak, D.
    Jacobi, P. M.
    Haberichter, S. L.
    Brody, L. C.
    Mills, J. L.
    Molloy, A. M.
    Ginsburg, D.
    Li, J. Z.
    Desch, K. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (09) : 1888 - 1898
  • [44] Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
    Castaman, Giancarlo
    Linari, Silvia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1029 - 1037
  • [45] Profile of von Willebrand factor antigen & von Willebrand factor propeptide in an overall population of TIA and ischaemic stroke patients and in specific TOAST subgroups
    Tobin, W. O.
    Kinsella, J. A.
    Kavanagh, G. F.
    O'Donnell, J. S.
    McGrath, R. A.
    Collins, D. R.
    Coughlan, T.
    O'Neill, D.
    Egan, B.
    Tierney, S.
    Feeley, T. M.
    Murphy, R. P.
    McCabe, D. J. H.
    CEREBROVASCULAR DISEASES, 2013, 35 : 550 - 550
  • [46] von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli
    Murphy, Stephen J. X.
    Lim, Soon Tjin
    Hickey, Fionnuala
    Kinsella, Justin A.
    Smith, Deirdre R.
    Tierney, Sean
    Egan, Bridget
    Feeley, T. Martin
    Murphy, Sinead M.
    Collins, D. Ronan
    Coughlan, Tara
    O'Neill, Desmond
    Harbison, Joseph A.
    Madhavan, Prakash
    O'Neill, Sean M.
    Colgan, Mary-Paula
    O'Donnell, James S.
    O'Sullivan, Jamie M.
    Hamilton, George
    McCabe, Dominick J. H.
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (01) : 86 - 97
  • [47] The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay
    Meiring, S. M.
    Setlai, B. D. P.
    Theron, C.
    Bragg, R.
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [48] Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand Disease
    O'Donnell, James S.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (02): : 192 - 200
  • [49] Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes
    Tobin, W. O.
    Kinsella, J. A.
    Kavanagh, G. F.
    O'Donnell, J. S.
    McGrath, R. T.
    Tierney, S.
    Egan, B.
    Feeley, T. M.
    Coughlan, T.
    Collins, D. R.
    O'Neill, D.
    Murphy, S. J. X.
    Lim, S. J.
    Murphy, R. P.
    McCabe, D. J. H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 375 : 404 - 410
  • [50] von Willebrand factor propeptide to antigen ratio identifies platelet activation and reduced von Willebrand factor survival phenotype in mice
    Jacobi, P. M.
    Kanaji, S.
    Jakab, D.
    Gehrand, A. L.
    Johnsen, J. M.
    Haberichter, S. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (03) : 546 - 554
12345